Format

Send to

Choose Destination
Arch Neurol. 2006 Jun;63(6):902-5.

Novel mitochondrial transfer RNA(Phe) gene mutation associated with late-onset neuromuscular disease.

Author information

1
Department of Neurology, Martin-Luther-Universit├Ąt Halle-Wittenberg, Halle/Saale, Germany.

Abstract

BACKGROUND:

An extensive range of molecular defects have been identified in the human mitochondrial genome (mitochondrial DNA); many are associated with well-characterized, progressive neurological syndromes, but a minority of patients have uncharacteristic phenotypes in which symptoms may be relatively mild.

OBJECTIVE:

To describe a novel transfer RNA(Phe) mutation of mitochondrial DNA in a late-onset case with a mild phenotype of mitochondrial disease.

DESIGN:

Case report.

PATIENT:

A 66-year-old woman presented with a 4-year history of walking difficulties due to exercise intolerance and paresthesia in the feet. Clinical examination results were normal. Her deceased mother had similar walking difficulties, but her sister and 2 children were unaffected.

RESULTS:

The demonstration of a marked histochemical defect in cytochrome c oxidase activity on muscle biopsy prompted molecular investigation of mitochondrial DNA, revealing a novel maternally inherited mutation in the variable loop of the mitochondrial transfer RNA(Phe) gene. This 622G>A transition was heteroplasmic and segregated with cytochrome c oxidase deficiency in single fibers.

CONCLUSION:

This case serves to illustrate that primary defects of the mitochondrial genome should be considered even in older patients with late-onset, mild neuromuscular symptoms.

PMID:
16769874
DOI:
10.1001/archneur.63.6.902
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center